The document discusses the process for getting COVID-19 related medical devices authorized under FDA Emergency Use Authorization (EUA), highlighting the importance of compliance with quality systems and regulatory requirements. It includes an overview of essential EUAs, diagnostic classifications, testing requirements, and labeling processes for such devices. The content emphasizes the expedited path to market for devices during emergencies and provides resources for manufacturers to ensure they meet regulatory standards.
Related topics: